
Despite their use of zzso zzso therapies, cancer patients continue to consider zzso zzso and vomiting zzso to be a significant zzso Patients frequently use various zzso medications for these zzso Unfortunately, there is a paucity of trials regarding treatment of breakthrough zzso This study investigated the efficacy of zzso a topical gel containing zzso zzso zzso zzso and zzso zzso in reducing breakthrough zzso Adults receiving standard recommended zzso zzso as zzso were instructed to use zzso zzso of the gel zzso when they experienced significant zzso Patients then were contacted zzso to respond to a questionnaire rating their zzso and/or vomiting and their response to zzso zzso The results were collected during two zzso Trial I began in April 2003, and Trial II began in March zzso During Trial I, 23 patients were zzso 17 patients zzso reported that use of the gel decreased their zzso with 15 zzso reporting relief within 30 minutes of its zzso Three patients believed that the gel caused zzso no troubles with skin irritation or muscle spasms were zzso In Trial II, all 10 patients believed that the treatment was zzso When the severity of zzso was zzso on a scale of zzso the mean zzso score decreased significantly from a zzso before gel application to a zzso as evaluated 30 minutes following gel application zzso zzso zzso zzso use of zzso gel appears to be a promising and safe rescue therapy for breakthrough zzso that occurs despite zzso zzso zzso These results warrant further confirmation in a large, randomized, zzso zzso 

